These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 11574913)

  • 1. Trimethoprim-sulfamethoxazole (TMP-SMZ) dose escalation versus direct rechallenge for Pneumocystis Carinii pneumonia prophylaxis in human immunodeficiency virus-infected patients with previous adverse reaction to TMP-SMZ.
    Leoung GS; Stanford JF; Giordano MF; Stein A; Torres RA; Giffen CA; Wesley M; Sarracco T; Cooper EC; Dratter V; Smith JJ; Frost KR;
    J Infect Dis; 2001 Oct; 184(8):992-7. PubMed ID: 11574913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of atovaquone and azithromycin with trimethoprim-sulfamethoxazole for the prevention of serious bacterial infections in children with HIV infection.
    Hughes WT; Dankner WM; Yogev R; Huang S; Paul ME; Flores MA; Kline MW; Wei LJ;
    Clin Infect Dis; 2005 Jan; 40(1):136-45. PubMed ID: 15614703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A prospective randomized trial comparing the toxicity and safety of atovaquone with trimethoprim/sulfamethoxazole as Pneumocystis carinii pneumonia prophylaxis following autologous peripheral blood stem cell transplantation.
    Colby C; McAfee S; Sackstein R; Finkelstein D; Fishman J; Spitzer T
    Bone Marrow Transplant; 1999 Oct; 24(8):897-902. PubMed ID: 10516703
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of the effectiveness of three regimens in the prevention of Pneumocystis carinii pneumonia in human immunodeficiency virus-infected patients.
    Martin MA; Cox PH; Beck K; Styer CM; Beall GN
    Arch Intern Med; 1992 Mar; 152(3):523-8. PubMed ID: 1546914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of trimethoprim-sulfamethoxazole, dapsone, and pentamidine in the prophylaxis of Pneumocystis carinii pneumonia.
    Warnock AC; Rimland D
    Pharmacotherapy; 1996; 16(6):1030-8. PubMed ID: 8947975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trimethoprim-sulfamethoxazole compared with ciprofloxacin for the prevention of urinary tract infection in renal transplant recipients. A double-blind, randomized controlled trial.
    Hibberd PL; Tolkoff-Rubin NE; Doran M; Delvecchio A; Cosimi AB; Delmonico FL; Auchincloss H; Rubin RH
    Online J Curr Clin Trials; 1992 Aug; Doc No 15():[4083 words; 46 paragraphs]. PubMed ID: 1343609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A prospective, randomized, double-blind study of trimethoprim-sulfamethoxazole for prophylaxis of infection in renal transplantation. Side effects of trimethoprim-sulfamethoxazole, interaction with cyclosporine.
    Maki DG; Fox BC; Kuntz J; Sollinger HW; Belzer FO
    J Lab Clin Med; 1992 Jan; 119(1):11-24. PubMed ID: 1727903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low-dose intermittent trimethoprim-sulfamethoxazole for prevention of Pneumocystis carinii pneumonia in patients with human immunodeficiency virus infection.
    Wormser GP; Horowitz HW; Duncanson FP; Forseter G; Javaly K; Alampur SK; Gilroy SA; Lenox T; Rappaport A; Nadelman RB
    Arch Intern Med; 1991 Apr; 151(4):688-92. PubMed ID: 1901482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prophylaxis with trimethoprim-sulfamethoxazole for human immunodeficiency virus-infected patients: impact on risk for infectious diseases.
    Dworkin MS; Williamson J; Jones JL; Kaplan JE;
    Clin Infect Dis; 2001 Aug; 33(3):393-8. PubMed ID: 11438910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prophylaxis of Pneumocystis carinii pneumonia with atovaquone in children with leukemia.
    Madden RM; Pui CH; Hughes WT; Flynn PM; Leung W
    Cancer; 2007 Apr; 109(8):1654-8. PubMed ID: 17345613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Sulfamethoxazole-trimethoprim-induced pneumonitis in a patient with hemophilia B who was infected with the human immunodeficiency virus].
    Yamagishi T; Yoshida S; Fukutake K; Utsumi K; Ichinose Y
    Nihon Kyobu Shikkan Gakkai Zasshi; 1996 Jul; 34(7):822-8. PubMed ID: 8810766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized trial of daily and thrice-weekly trimethoprim-sulfamethoxazole for the prevention of Pneumocystis carinii pneumonia in human immunodeficiency virus-infected persons. Terry Beirn Community Programs for Clinical Research on AIDS (CPCRA).
    El-Sadr WM; Luskin-Hawk R; Yurik TM; Walker J; Abrams D; John SL; Sherer R; Crane L; Labriola A; Caras S; Pulling C; Hafner R
    Clin Infect Dis; 1999 Oct; 29(4):775-83. PubMed ID: 10589887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors for community-acquired pneumonia among persons infected with human immunodeficiency virus.
    Navin TR; Rimland D; Lennox JL; Jernigan J; Cetron M; Hightower A; Roberts JM; Kaplan JE
    J Infect Dis; 2000 Jan; 181(1):158-64. PubMed ID: 10608762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid disease progression in human immunodeficiency virus type 1-infected individuals with adverse reactions to trimethoprim-sulfamethoxazole prophylaxis.
    Veenstra J; Veugelers PJ; Keet IP; van der Ven AJ; Miedema F; Lange JM; Coutinho RA
    Clin Infect Dis; 1997 May; 24(5):936-41. PubMed ID: 9142796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of twice-weekly pyrimethamine-sulfadoxine as primary prophylaxis of Pneumocystis carinii pneumonia and toxoplasmic encephalitis in patients with advanced HIV infection.
    Schürmann D; Bergmann F; Albrecht H; Padberg J; Wünsche T; Grünewald T; Schürmann M; Grobusch M; Vallée M; Ruf B; Suttorp N
    Eur J Clin Microbiol Infect Dis; 2002 May; 21(5):353-61. PubMed ID: 12072919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ineffectiveness of trimethoprim-sulfamethoxazole prophylaxis and the importance of bacterial and viral coinfections in African children with Pneumocystis carinii pneumonia.
    Madhi SA; Cutland C; Ismail K; O'Reilly C; Mancha A; Klugman KP
    Clin Infect Dis; 2002 Nov; 35(9):1120-6. PubMed ID: 12384847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of Pneumocystis carinii pneumonia relapse in AIDS patients. The efficacy and tolerability of low-dose sulfamethoxazole-trimethoprim.
    Nielsen TL; Jensen BN; Nelsing S; Pedersen C; Mathiesen LR; Skinhøj P; Nielsen JO
    Dan Med Bull; 1993 Sep; 40(4):503-5. PubMed ID: 8222772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discontinuation of primary prophylaxis for Pneumocystis carinii pneumonia and toxoplasmic encephalitis in human immunodeficiency virus type I-infected patients: the changes in opportunistic prophylaxis study.
    Mussini C; Pezzotti P; Govoni A; Borghi V; Antinori A; d'Arminio Monforte A; De Luca A; Mongiardo N; Cerri MC; Chiodo F; Concia E; Bonazzi L; Moroni M; Ortona L; Esposito R; Cossarizza A; De Rienzo B
    J Infect Dis; 2000 May; 181(5):1635-42. PubMed ID: 10823763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A multicenter randomized double-blind placebo-controlled trial of adjunctive corticosteroids in the treatment of Pneumocystis carinii pneumonia complicating the acquired immune deficiency syndrome.
    Walmsley S; Levinton C; Brunton J; Muradali D; Rappaport D; Bast M; Spence D; Salit I
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Apr; 8(4):348-57. PubMed ID: 7882099
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resistance to trimethoprim-sulfamethoxazole.
    Huovinen P
    Clin Infect Dis; 2001 Jun; 32(11):1608-14. PubMed ID: 11340533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.